| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP, GC &Business Development | General Counsel
1 company
Olivo Alicia C is an EVP, GC &Business Development at NEO. Recent filings cover 0 purchases and 7 sales.
Our model assigns Olivo Alicia C a middling insider score of 69/100, based on 7 past trades. Over a 12-month horizon, 100.0% of those trades were profitable, with an average 12-month return of +33.3%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 25, 2025 | NEO Neogenomics Inc | EVP, GC &Business Development | Sale+OE10b5-1 | 20,916 | $12.00 | $250,992.00 | -40.2% | -19.2% | - | |
| Oct 16, 2025 | NEO Neogenomics Inc | EVP, GC &Business Development | Sell10b5-1 | 4,918 | $10.00 | $49,180.00 | -10.3% | +28.6% | +62.0% | |
| Nov 15, 2024 | NEO Neogenomics Inc | General Counsel | Sell10b5-1 | 5,175 | $15.36 | $79,475.06 | -12.2% | -7.5% | -31.2% | |
| Aug 15, 2024 | NEO Neogenomics Inc | General Counsel | Sell10b5-1 | 1,040 | $16.05 | $16,695.43 | -2.3% | +1.9% | -61.5% | |
| May 15, 2024 | NEO Neogenomics Inc | General Counsel | Sell10b5-1 | 1,049 | $15.74 | $16,511.26 | -2.3% | +8.9% | -48.2% | |
| Feb 15, 2024 | NEO Neogenomics Inc | General Counsel | Sell10b5-1 | 2,587 | $14.96 | $38,712.90 | -6.9% | +1.5% | -3.2% | |
| Nov 17, 2023 | NEO Neogenomics Inc | General Counsel | Sell10b5-1 | 2,669 | $18.39 | $49,082.91 | -6.7% | -23.2% | -22.5% |